134 related articles for article (PubMed ID: 32415496)
1. Lipid biosignature of breast cancer tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Silva CL; Perestrelo R; Sousa-Ferreira I; Capelinha F; Câmara JS; Petković M
Breast Cancer Res Treat; 2020 Jul; 182(1):9-19. PubMed ID: 32415496
[TBL] [Abstract][Full Text] [Related]
2. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
[TBL] [Abstract][Full Text] [Related]
3. Lipid profiles for HER2-positive breast cancer.
Kim IC; Lee JH; Bang G; Choi SH; Kim YH; Kim KP; Kim HK; Ro J
Anticancer Res; 2013 Jun; 33(6):2467-72. PubMed ID: 23749897
[TBL] [Abstract][Full Text] [Related]
4. Parameters affecting the accuracy of the MALDI-TOF MS determination of the phosphatidylcholine/lysophosphatidylcholine (PC/LPC) ratio as potential marker of spermatozoa quality.
Bresler K; Pyttel S; Paasch U; Schiller J
Chem Phys Lipids; 2011 Oct; 164(7):696-702. PubMed ID: 21827741
[TBL] [Abstract][Full Text] [Related]
5. 2,5-dihydroxybenzoic acid salts for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric lipid analysis: simplified spectra interpretation and insights into gas-phase fragmentation.
Jaskolla TW; Onischke K; Schiller J
Rapid Commun Mass Spectrom; 2014 Jun; 28(12):1353-63. PubMed ID: 24797946
[TBL] [Abstract][Full Text] [Related]
6. Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer.
Sun Y; Zhang J; Guo F; Zhao W; Zhan Y; Liu C; Fan Y; Wang J
Med Sci Monit; 2016 Apr; 22():1152-60. PubMed ID: 27052600
[TBL] [Abstract][Full Text] [Related]
7. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research.
Schiller J; Süss R; Arnhold J; Fuchs B; Lessig J; Müller M; Petković M; Spalteholz H; Zschörnig O; Arnold K
Prog Lipid Res; 2004 Sep; 43(5):449-88. PubMed ID: 15458815
[TBL] [Abstract][Full Text] [Related]
8. Potential of MALDI-TOF-based serum N-glycan analysis for the diagnosis and surveillance of breast cancer.
Lee JW; Lee K; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Choi S; Chang S; Ko CK; Lee SB; Kim DC
Sci Rep; 2020 Nov; 10(1):19136. PubMed ID: 33154535
[TBL] [Abstract][Full Text] [Related]
9. A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Cheng Z; Winant RC; Gambhir SS
J Nucl Med; 2005 May; 46(5):878-86. PubMed ID: 15872363
[TBL] [Abstract][Full Text] [Related]
10. Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis.
Cho YT; Su H; Huang TL; Chen HC; Wu WJ; Wu PC; Wu DC; Shiea J
Clin Chim Acta; 2013 Jan; 415():266-75. PubMed ID: 23089072
[TBL] [Abstract][Full Text] [Related]
11. Surface analysis of lipids by mass spectrometry: more than just imaging.
Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylcholine removal from brain lipid extracts expands lipid detection and enhances phosphoinositide quantification by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.
Johanson RA; Buccafusca R; Quong JN; Shaw MA; Berry GT
Anal Biochem; 2007 Mar; 362(2):155-67. PubMed ID: 17266916
[TBL] [Abstract][Full Text] [Related]
13. MALDI-TOF MS in lipidomics.
Schiller J; Suss R; Fuchs B; Muller M; Zschornig O; Arnold K
Front Biosci; 2007 Jan; 12():2568-79. PubMed ID: 17127263
[TBL] [Abstract][Full Text] [Related]
14. MALDI-TOF Mass Spectrometry Based on Parylene-Matrix Chip for the Analysis of Lysophosphatidylcholine in Sepsis Patient Sera.
Park JM; Noh JY; Kim MJ; Yun TG; Lee SG; Chung KS; Lee EH; Shin MH; Ku NS; Yoon S; Kang MJ; Park MS; Pyun JC
Anal Chem; 2019 Nov; 91(22):14719-14727. PubMed ID: 31621295
[TBL] [Abstract][Full Text] [Related]
15. Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype.
Kang HS; Lee SC; Park YS; Jeon YE; Lee JH; Jung SY; Park IH; Jang SH; Park HM; Yoo CW; Park SH; Han SY; Kim KP; Kim YH; Ro J; Kim HK
BMC Cancer; 2011 Oct; 11():465. PubMed ID: 22029885
[TBL] [Abstract][Full Text] [Related]
16. High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer.
Li X; Nakayama K; Goto T; Kimura H; Akamatsu S; Hayashi Y; Fujita K; Kobayashi T; Shimizu K; Nonomura N; Ogawa O; Inoue T
Cancer Sci; 2021 Oct; 112(10):4292-4302. PubMed ID: 34328656
[TBL] [Abstract][Full Text] [Related]
17. Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI-TOF mass spectrometry.
Serna J; García-Seisdedos D; Alcázar A; Lasunción MÁ; Busto R; Pastor Ó
Chem Phys Lipids; 2015 Jul; 189():7-18. PubMed ID: 26004846
[TBL] [Abstract][Full Text] [Related]
18. Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.
de Vega RG; Sanchez MLF; Eiro N; Vizoso FJ; Sperling M; Karst U; Medel AS
Anal Bioanal Chem; 2018 Jan; 410(3):913-922. PubMed ID: 28801789
[TBL] [Abstract][Full Text] [Related]
19. Matrix-assisted laser desorption/ionization mass spectrometry imaging of cell cultures for the lipidomic analysis of potential lipid markers in human breast cancer invasion.
Wang S; Chen X; Luan H; Gao D; Lin S; Cai Z; Liu J; Liu H; Jiang Y
Rapid Commun Mass Spectrom; 2016 Feb; 30(4):533-42. PubMed ID: 26777684
[TBL] [Abstract][Full Text] [Related]
20. Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt.
Zaki A; Ramadan RA; Moez P; Ghareeb H; Elkarmouty A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):175-184. PubMed ID: 30678429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
